Latest placebo Stories
- Study successfully meets primary endpoint- Lack of sleep-related side effects supports flexible nighttime dosing platform to target control over symptoms during the morning routine-
Dupilumab Demonstrated Improvement in Lung Function, Reductions of Severe Exacerbations TARRYTOWN, N.Y. and PARIS, Nov. 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Saint Luke’s Mid America Heart Institute researchers discover many of the most commonly prescribed medications are not effective for reducing cardiovascular events. Kansas
LUGANO, Switzerland, October 30, 2014 /PRNewswire/ -- In ROMANA 1, a pivotal Phase III study, anamorelin was shown to increase lean body mass and body weight, reduce fatigue
REHOVOT, Israel, October 29, 2014 /PRNewswire/ -- Company also reports encouraging partial results from Phase IIa study of continuous, subcutaneously delivered high-dose
Pasteurized agave nectar and placebo were both perceived to be better by parents for treating nighttime cough and the resulting sleep difficulty in infants and toddlers than doing nothing at all
Results indicate Zalviso controlled moderate-to-severe acute pain following abdominal surgery better than placebo, with similar side effect profile REDWOOD CITY, Calif., Oct.
- Growing in low tufty patches.